Genetic Variations Between Populations Drive New Cancer Trial Standards
Cancer treatment efficacy varies dramatically across populations due to genetic differences that pharmaceutical companies can no longer ignore. Regulatory…
Found 2067 results for "cancer"
Cancer treatment efficacy varies dramatically across populations due to genetic differences that pharmaceutical companies can no longer ignore. Regulatory…
Cancer defense mechanisms may trace back hundreds of millions of years through evolutionary history, offering new therapeutic angles that bypass conventional…
The foundational understanding of how adhesion G-protein coupled receptors initiate cellular responses may need revision, with implications for developing…
Cancer patients with specific genetic mutations often watch promising immunotherapies fail where they succeed for others. This stark reality affects roughly…
Understanding how brain architecture forms during development could unlock new approaches to neurological disorders and cognitive enhancement. The precise…
Nearly half of women possess breast tissue dense enough to obscure tumors on standard mammograms, creating a diagnostic blind spot that allows cancers to…
The promise of artificial intelligence accelerating medical breakthroughs has largely remained theoretical—until now. A new computational framework…
The gap between medical procedure anxiety and actual experience reveals important insights for clinical decision-making. While patients consistently…
The trajectory of women's health faces a critical inflection point as breast cancer patterns shift dramatically across global populations, with emerging…
Adoptive T cell therapies face a fundamental limitation: the stem-like memory T cells that provide lasting immunity are notoriously difficult to generate in…
Drug resistance remains one of the most formidable barriers in cancer treatment, turning initially effective therapies into futile interventions. This…
Chromosomal stability represents a crucial battleground in cancer prevention, with new evidence revealing how a previously understudied cellular quality…
The glaring omission of cancer risk assessment in global obesity treatment frameworks could leave millions of high-risk patients without access to potentially…
A dramatic reversal in America's cancer mortality geography reveals profound health equity challenges that could reshape prevention strategies nationwide…
The gap between laboratory discoveries and clinical treatments for bone diseases may be narrowing through sophisticated microengineering that recreates human…
The boundary between curable and incurable cancer may be shifting as oncologists explore aggressive treatment of limited metastatic disease. This approach…
Age emerges as the critical factor determining whether colorectal cancer survivors face elevated risks for developing additional primary cancers later in…
Invisible plastic fragments now circulating through human tissues may represent one of the most underestimated carcinogenic threats of the modern era. As…
The path to eliminating one of medicine's most aggressive liver diseases may already exist in our vaccination toolkit. Hepatitis D virus represents the most…
Cancer's ability to colonize bones represents one of oncology's most persistent challenges, transforming skeletal tissue into sanctuaries where tumors evade…